Clinical Trial Update: MSC2364447C Phase 1b in Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1b clinical trial of MSC2364447C in systemic lupus erythematosus. The study was sponsored by EMD Serono Research…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• MSC2364447C

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Lupus Erythematosus, Systemic | Phase 1 | Status: COMPLETED